Drug Search Results

PROSTVAC

Alternative Names: PROSTVAC, prostvac-v, prostvac-f, prostvac-vf, prostvac-v/f, PSA-TRICOM, rilimogene galvacirepvec, rilimogene glafolivec
Latest Update: 2024-08-06
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: TCR Activator

Novel Mechanism: Yes

Modality: Vaccine

Route of Administration: Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Bavarian Nordic
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for PROSTVAC

Countries in Clinic: United States

Active Clinical Trial Count: 2

Highest Development Phases

Phase 2: Prostate Cancer

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
NCT02772562	P2	Completed	Prostate Cancer	2024-04-29
CA209-9MW	P1	Completed	Prostate Cancer	2022-04-01

Recent News Events

Date	Type	Title
10/28/2023	PubMed	Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis.
10/17/2023	PubMed	Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide.
07/05/2023	PubMed	Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
09/28/2021	News Article	Enara Bio announces the appointment of highly experienced biotech executive Dr. Robert Ang to its Board of Directors
03/16/2021	News Article	Global Prostate Cancer Update Bulletin - Key Opinion Leader Insights into Recent Market Developments - ResearchAndMarkets.com
02/14/2020	News Article	Increasing Clinical Development Activities Driving the Prostate Cancer Vaccines Market
08/15/2019	News Article	Bavarian Nordic Announces First Half 2019 Results

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions